PEDEvidence@pedevidence

Insulin

What it is & what research shows

Overview incomplete

Insulin is listed as a peptide in the metabolism section of this catalog. Also indexed as human insulin. A source-verified explanation of its mechanism and uses has not yet been completed here; the catalog category is not evidence of benefit.

A source-linked synthesis of findings, studied doses, routes, schedules and limitations has not yet been completed for this compound. No dose or benefit is inferred from its name, category or mechanism. This describes the coverage of this page, not the absence of research in the wider literature.

Studied methods, not dosing advice. Selected evidence, not a complete literature review or formal quality appraisal.

By PED Evidence

Source scope is listed with each reference. Prepared by PED Evidence with AI assistance. Independent clinician review has not been completed. Review standards

Evidence summarized on PED Evidence

20 completed summaries

12 human-study reports

7 randomized-trial candidates

5 safety-topic reports

These counts describe completed summaries on this site, not the size of the full literature. Publications can share participants; design labels are discovery metadata, not appraisals.

Landmark reading

Editorial selections, not an effectiveness ranking or recommendation.

Filter, save and compare Insulin studies →
More about Insulin: identity, safety & reference details
PeptideMetabolism
Primary research area
Emerging research
Regulatory status
Research status varies
Evidence level
Evidence level not yet characterized
Primary mechanism
Mechanism not yet characterized
Reference profile incomplete · Coverage varies by section

Also known as human insulin

Start with the research

An outcome-specific synthesis has not been prepared for this compound. This is a coverage gap, not evidence that it has no effect.

Open studies and trial records
Uses & research

Uses have not been independently checked for this profile. Browse the original studies to see the conditions and populations investigated.

Known half-life

No source-verified value in this profile yet. A treatment schedule or duration of an effect is not a drug half-life.

Half-life describes how quickly the measured drug concentration falls by half. It does not set a dosing interval.
Evidence & important limits

A catalog entry does not establish effectiveness, safety or approval. Study findings and quality appraisal remain separate.

Safety & evidence boundaries

Source-specific information, not a personal safety clearance or monitoring plan.

A compound-specific safety synthesis is not available here yet. Lack of listed adverse effects does not establish safety.

Explore safety questions by system

These are literature filters, not claims that this compound causes each effect. A keyword match is not a confirmed adverse reaction.

Heart, blood pressure & lipidsLiver injuryKidney functionGlucose effectsReproductive & endocrine effectsMood & sleepAdverse effects & interactions

Interactions, rare harms, long-term effects and reversibility require separate evidence. Do not infer they are absent when the sources here do not address them.

Identity, names & formulations

Canonical compound: Insulin · insulin

Searchable names: human insulin

Names share a parent research page. Different esters, salts, routes and brands are not assumed to have the same half-life, indication or exposure.

Combination evidence stays attached to the studied combination. It is not automatically assigned to each ingredient.

Understand the evidence types

Read the model and design first, then the population, outcome and limitations. These categories describe evidence, not a best-compound ranking.

Randomized human trials
Compare assigned interventions. Randomization does not by itself establish low bias or relevance to every population.
Controlled human studies
Use a comparison group; allocation and confounding still matter.
Prospective human research
Follows participants forward. It may be observational or interventional, so this is not a separate quality grade.
Observational human research
Describes associations. Confounding can explain differences.
Case reports and series
Useful for unusual events and safety signals, not reliable rates or effect sizes.
Animal research
Can test biology and function in a living model. Human exposure, benefit and safety remain separate questions.
Cell and tissue research
Tests responses in a preparation, including human-derived cells. It is not a human participant trial.
Mechanistic and computational evidence
Helps explain or predict a pathway; predictions need experimental and clinical testing.
Anecdotal reports
Self-reported experiences can generate questions. Product identity, selection bias and other interventions may be uncontrolled.

Systematic reviews synthesize studies and depend on their quality. Preprint status and abstract versus full-paper reading are separate labels. Citation popularity measures attention, not reliability. A study summary is not a formal quality appraisal.

Browse all studies

Study model describes the source. Confidence depends on methods, replication, population and outcome.

Loading compound research…

Insulin study summaries

Human-first reading order. Intervention candidates are distinguished from background mentions in the library.